Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
Submitted by
admin
on January 9, 2010 - 12:50pm
Source:
Trading Markets
News Tags:
Novelos Therapeutics
lung cancer
Headline:
Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
Do Not Allow Advertisers to Use My Personal information
